WHO Releases Guidelines For Injectable HIV Prevention Drug, Generics Deal Reached - CodeBlue

ViiV Healthcare has agreed to allow selected manufacturers to produce generic versions of its long-acting injectable cabotegravir, Apretude.

MONTREAL, July 29 The World Health Organization (WHO) announced Thursday new guidelines for long-acting cabotegravir (CAB-LA), the first injectable medication to prevent HIV, calling for countries to… [+4246 chars]

full article...